• Vivekanand Jha, Dominique E Martin, Joanne M Bargman, Simon Davies, John Feehally, Fred Finkelstein, David Harris, Madhukar Misra, Giuseppe Remuzzi, Adeera Levin, and International Society of Nephrology Ethical Dialysis Task Force.
• The George Institute for Global Health, New Delhi, India; University of Oxford, Oxford, UK. Electronic address: vivek.jha@georgeinstitute.ox.ac.uk.
• Lancet. 2017 May 6; 389 (10081): 1851-1856.

AbstractTreatment for end-stage kidney disease is a major economic challenge and a public health concern worldwide. Renal-replacement therapy poses several practical and ethical dilemmas of global relevance for patients, clinicians, and policy makers. These include how to: promote patients' best interests; increase access to dialysis while maintaining procedural and distributive justice; minimise the influence of financial incentives and competing interests; ensure quality of care in service delivery and access to non-dialytic supportive care when needed; minimise the financial burden on patients and health-care system; and protect the interests of vulnerable groups during crisis situations. These issues have received comparatively little attention, and there is scant ethical analysis and guidance available to decision makers. In this Health Policy, we provide an overview of the major ethical issues related to dialysis provision worldwide, identify priorities for further investigation and management, and present preliminary recommendations to guide practice and policy.Copyright © 2017 Elsevier Ltd. All rights reserved.

21 keywords...

hide…